Theoretically, an altered ratio of Bcl-2/Bax causes downstream activation of caspase cascades (such as caspase 8), ultimately leading to the activation of cleaved caspase 348–50, which was observed in glioma cells after treatment with α-m-Dox/M. Here, BCL2 is linked to central nervous system cancer.